GEN has retained its position as the number one biotech publisher around the globe since its launch in 1981, with a print edition, additional content online, and a networking platform, GENconnect. Wed, 23 May 2012 07:13:33 -0400 http://www.genengnews.com/media/files/rss/TRANSLATIONAL-MEDICINE-orphan-diseases.xml http://www.genengnews.com/gen-news-highlights/intermune-sells-actimmune-to-vidara-for-55m/81246797/ http://www.genengnews.com/gen-news-highlights/intermune-sells-actimmune-to-vidara-for-55m/81246797/ Tue, 22 May 2012 07:15:00 -0400